← Back to headlines
Iovance Stock Rises on Australian Approval of Melanoma Therapy Amtagvi
Iovance Biotherapeutics shares increased after Australia granted approval for its melanoma therapy, Amtagvi, marking a significant regulatory milestone for the company.
4 Jun, 16:27 — 4 Jun, 16:27
Sources
Showing 1 of 1 sources
Related Stories
NATO Warns of Escalating Russian Gray Zone Attacks Across Europe
34m ago
Trump Administration Announces Major Oil Deal to Replenish U.S. Strategic Reserve
40m ago
Investors Eye Jobs Data and Major Earnings Reports for Market Direction
54m ago
North Korea Replaces Defense Minister in Military Shake-Up
2h ago